全文获取类型
收费全文 | 4019篇 |
免费 | 246篇 |
国内免费 | 120篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 271篇 |
妇产科学 | 52篇 |
基础医学 | 363篇 |
口腔科学 | 99篇 |
临床医学 | 533篇 |
内科学 | 813篇 |
皮肤病学 | 118篇 |
神经病学 | 115篇 |
特种医学 | 672篇 |
外科学 | 396篇 |
综合类 | 251篇 |
预防医学 | 223篇 |
眼科学 | 35篇 |
药学 | 198篇 |
4篇 | |
中国医学 | 32篇 |
肿瘤学 | 193篇 |
出版年
2022年 | 33篇 |
2021年 | 46篇 |
2020年 | 41篇 |
2019年 | 22篇 |
2018年 | 50篇 |
2017年 | 43篇 |
2016年 | 40篇 |
2015年 | 74篇 |
2014年 | 98篇 |
2013年 | 132篇 |
2012年 | 111篇 |
2011年 | 119篇 |
2010年 | 177篇 |
2009年 | 187篇 |
2008年 | 118篇 |
2007年 | 166篇 |
2006年 | 130篇 |
2005年 | 104篇 |
2004年 | 72篇 |
2003年 | 66篇 |
2002年 | 73篇 |
2001年 | 72篇 |
2000年 | 55篇 |
1999年 | 55篇 |
1998年 | 211篇 |
1997年 | 230篇 |
1996年 | 205篇 |
1995年 | 175篇 |
1994年 | 155篇 |
1993年 | 145篇 |
1992年 | 40篇 |
1991年 | 54篇 |
1990年 | 49篇 |
1989年 | 84篇 |
1988年 | 90篇 |
1987年 | 81篇 |
1986年 | 78篇 |
1985年 | 77篇 |
1984年 | 45篇 |
1983年 | 38篇 |
1982年 | 40篇 |
1981年 | 39篇 |
1980年 | 41篇 |
1977年 | 32篇 |
1976年 | 39篇 |
1959年 | 23篇 |
1958年 | 32篇 |
1956年 | 30篇 |
1955年 | 46篇 |
1954年 | 38篇 |
排序方式: 共有4385条查询结果,搜索用时 15 毫秒
11.
Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma 总被引:9,自引:3,他引:6
Weisenburger DD; Gordon BG; Vose JM; Bast MA; Chan WC; Greiner TC; Anderson JR; Sanger WG 《Blood》1996,87(9):3860-3868
Primary CD30(Ki-1)-positive anaplastic large-cell lymphoma (ALCL) is considered by some to be a distinct clinicopathologic entity associated with the t(2;5) (p23;q35). However, the specificity of t(2;5) for ALCL has not been carefully studied. Therefore, we performed a detailed analysis of all cases of ALCL with abnormal cytogenetics results in the Nebraska Lymphoma Study Group registry, as well as all other cases of non-Hodgkin's lymphoma with t(2;5) in the registry. We found the t(2;5) in only five of 10 cases of ALCL, four of whom were young patients. However, we also found the t(2;5) in 11 other cases of nonanaplastic lymphoma, including eight children with typical peripheral T-cell lymphomas of various types. The t(2;5) was also found in three older adults with B-cell lymphomas of various types. Thus, the t(2;5) was not specific for CD30+ ALCL. However, t(2;5) may define a clinicopathologic entity in children and young adults characterized by variable morphologies with a T-cell or indeterminate phenotype, CD30-positivity, nodal disease with frequent extranodal involvement, advanced stage, and an excellent response to therapy, including bone marrow transplantation for relapsed disease. The clinical relevance of the t(2;5) in older patients requires further study. 相似文献
12.
13.
14.
Philip Peng FRCPC Manon Choiniere PhD Dominique Dion MD MSc Howard Intrater FRCPC Sandra LeFort PhD Mary Lynch FRCPC May Ong FRCPC Saifee Rashiq MSc DA FRCPC Gregg Tkachuk PhD Yves Veillette FRCPC 《Journal canadien d'anesthésie》2007,54(12):977-984
PURPOSE: The objective of this survey was to examine the services offered by multidisciplinary pain treatment facilities (MPTFs) across Canada and to compare access to care at these MPTFs. METHODS: A MPTF was defined as a clinic that advertised specialized multidisciplinary services for the diagnosis and management of patients with chronic pain, having a minimum of three different health care disciplines (including at least one medical speciality) available and integrated within the facility. The search method included approaching all hospital and rehabilitation centre administrators in Canada, the Insurance Bureau of Canada, the Workplace Safety and Insurance Board or similar body in each province. Designated investigators were responsible for confirming and supplementing MPTFs from the preliminary list for each province. Administrative leads at each eligible MPTF were asked to complete a detailed questionnaire regarding their MPTF infrastructure, clinical, research, teaching and administrative activities. RESULTS: Completed survey forms were received from 102 MPTFs (response rate 85%) with 80% concentrated in major cities, and none in Prince Edward Island and the Territories. The MPTFs offer a wide variety of treatments including non-pharmacological modalities such as interventional, physical and psychological therapy. The median wait time for a first appointment in public MPTFs is six months, which is approximately 12 times longer than non-public MPTFs. Eighteen pain fellowship programs exist in Canadian MPTFs and 64% engage in some form of research activities CONCLUSION: Canadian MPTFs are unable to meet clinical demands of patients suffering from chronic pain, both in terms of regional accessibility and reasonable wait time for patients' first appointment. 相似文献
15.
16.
17.
18.
19.
20.